Search

Glaukos Corp

Gesloten

SectorGezondheidszorg

223.52 2.05

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

218.07

Max

228.55

Belangrijke statistieken

By Trading Economics

Inkomsten

20M

2M

Verkoop

25M

211M

EPS

0.47

Winstmarge

0.956

Werknemers

1,094

EBITDA

18M

12M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+8.11% upside

Marktinformatie

By TradingEconomics

Marktkapitalisatie

3.6B

14B

Vorige openingsprijs

221.47

Vorige sluitingsprijs

223.52

Glaukos Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

6 nov 2026, 21:02 UTC

Glaukos Corporation is seeing higher trading activity with unusually high volume, peaking earlier in the day while remaining above its 20-day moving average.

5 nov 2026, 21:03 UTC

Glaukos Corporation shares fell sharply after a brief uptick, trading with unusually high volume while remaining above its 20-day moving average.

4 nov 2026, 21:02 UTC

Glaukos Corporation shares are advancing, supported by strong trading volume, despite earlier pulling back from a session high. The health care equipment sector shows positive momentum.

3 nov 2026, 20:51 UTC

Glaukos Corporation shares are declining, retracing from an earlier peak, despite remaining significantly above Monday's close amid unusually high trading volume.

2 nov 2026, 20:56 UTC

News
Social Media

Glaukos Corporation will be added to the S&P MidCap 400 index, a development that may enhance its visibility among investors.

30 okt 2026, 19:42 UTC

Social Media

Glaukos Corporation shares fell amid a broader market downturn, with unusually high trading volume today.

29 okt 2026, 20:03 UTC

Social Media
News

Stock advances after return to profitability, $2 million net income.

28 okt 2026, 23:02 UTC

Social Media
News

Glaukos Corporation reported record Q3 net sales of $211 million and raised its 2026 sales guidance to between $775 million and $785 million.

27 okt 2026, 20:01 UTC

Glaukos Corporation shares are experiencing higher trading activity today, reaching a notable peak earlier in the session before pulling back slightly.

26 okt 2026, 23:46 UTC

Glaukos Corp shares are trading higher in after-market hours, remaining near the upper end of their one-month trading range.

22 okt 2026, 20:07 UTC

Glaukos Corp shares are declining, retracing from an early session peak to approach the day's low amid a slight overall market decline.

21 okt 2026, 20:07 UTC

Glaukos Corp shares advanced throughout Wednesday, peaking in the afternoon before a slight pullback, remaining above their 20-day moving average.

20 okt 2026, 20:01 UTC

Glaukos Corp shares are significantly higher, currently 7.32% above their 20-day moving average and near the upper end of their one-month range.

16 okt 2026, 19:36 UTC

Glaukos Corp shares fell sharply, marking a notable decline since Thursday's close and currently positioned around the midpoint of its one-month trading range.

15 okt 2026, 20:07 UTC

Glaukos Corp shares are declining, reversing an early spike to finish lower from Wednesday's close amid unusual volatility.

13 okt 2026, 20:07 UTC

Glaukos Corp shares are declining, following a volatile intraday pattern, closing lower from Monday's close despite briefly recovering earlier in the session.

9 okt 2026, 20:06 UTC

News
Event

Glaukos reports positive Phase 4 trial results for iDose TR therapy, showing a significant reduction in intraocular pressure alongside cataract surgery, confirming safety.

8 okt 2026, 22:55 UTC

Glaukos Corp shares declined in after-market hours, continuing a downward trend from Thursday's close and remaining below its 20-day moving average.

7 okt 2026, 20:00 UTC

Glaukos Corp is advancing significantly with unusually high trading volume, marking a departure from recent higher daily closes since Tuesday.

6 okt 2026, 20:07 UTC

Glaukos Corp shares are declining, trading below their 20-day moving average and near the lower end of their one-month range after earlier volatility.

1 okt 2026, 20:07 UTC

Glaukos Corp's shares are declining, positioned near the lower end of their one-month range, after a brief spike earlier in the session.

30 sep 2026, 20:07 UTC

Glaukos Corp shares are advancing, rebounding from an earlier pullback, amid a broader market trend of significant gains on Wednesday.

29 sep 2026, 23:55 UTC

Glaukos Corp is trading modestly higher in after-market hours, despite fluctuations during the session, and remains below its 20-day moving average.

28 sep 2026, 20:07 UTC

Glaukos Corp is gaining ground in today's trading session, reflecting upward momentum since Friday, despite earlier pulling back from a session high.

25 sep 2026, 20:07 UTC

Glaukos Corp shares fell sharply, closing just below Thursday's close and approximately 9.45% below their 20-day moving average.

23 sep 2026, 20:01 UTC

News

Glaukos Corporation launched a keratoconus awareness campaign with Stephen Curry, but shares fell sharply today, continuing a trend of three consecutive daily declines.

22 sep 2026, 23:01 UTC

Glaukos Corp is advancing in after-market trading, reflecting a directional move since Tuesday's close, though it remains 6.99% below its 20-day moving average.

21 sep 2026, 20:06 UTC

Glaukos Corp's shares are declining, remaining below their 20-day moving average and near the lower end of their one-month range despite an earlier session recovery.

18 sep 2026, 20:02 UTC

Glaukos Corp is advancing during market hours on Friday, continuing its upward trend since Thursday's close, despite lower trading compared to earlier sessions.

17 sep 2026, 19:36 UTC

Glaukos Corp shares fell sharply, currently at their lowest point of the day and significantly below the 20-day moving average.

Peer Vergelijking

Prijswijziging

Glaukos Corp Prognose

Koersdoel

By TipRanks

8.11% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 237.818 USD  8.11%

Hoogste 255 USD

Laagste 210 USD

Gebaseerd op 11 Wall Street-analisten die 12-maands prijsdoelen bieden voor Glaukos Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

11 ratings

10

Buy

1

Hold

0

Sell

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Glaukos Corp

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
help-icon Live chat